Literature DB >> 21503824

Barriers in identification and referral to genetic counseling for familial cancer risk: the perspective of genetic service providers.

Sharon J Rolnick1, Alanna K Rahm, Jody M Jackson, Larissa Nekhlyudov, Katrina A B Goddard, Terry Field, Catherine McCarty, Cynthia Nakasato, Douglas Roblin, Christopher P Anderson, Rodolfo Valdez.   

Abstract

The purpose of this study was to obtain genetic counselors' perspectives about the identification of appropriate patients and barriers to referral of high-risk patients for cancer genetic counseling services. Genetic service providers from eight integrated health systems were surveyed. Data analysis included descriptive statistics. Twenty-eight of 40 potential participants responded (70%). Referrals for familial cancer risk assessment overwhelmingly came from providers (89%); only 10% were self-referrals. Use of guidelines to assist providers with referral was reported by 46% of the respondents. Genetic service providers perceived patient barriers to seeking genetic counseling after referral included: risk evaluation viewed as a non-priority (72%), concerns about impact on insurability (52%), distance to appointments (48%), lack of insurance (44%), lack of patient/provider knowledge about the value of genetic counseling (36%), discouragement by family members (28%), and fear (20%). The best approaches suggested by respondents to increase appropriate referrals were attending meetings and giving presentations to oncologists, surgeons, primary care and gynecologists. The genetic service providers reported several barriers to the referral and use of genetic counseling. This finding is consistent with current literature from the providers' perspective. Our survey adds the genetic service providers' perspective and identifies areas of opportunity for further research and intervention as few of the perceived barriers are being addressed through current educational efforts.

Entities:  

Mesh:

Year:  2011        PMID: 21503824     DOI: 10.1007/s10897-011-9351-3

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  44 in total

1.  Factors associated with decisions about clinical BRCA1/2 testing.

Authors:  K Armstrong; K Calzone; J Stopfer; G Fitzgerald; J Coyne; B Weber
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-11       Impact factor: 4.254

Review 2.  Building a research consortium of large health systems: the Cancer Research Network.

Authors:  Edward H Wagner; Sarah M Greene; Gene Hart; Terry S Field; Suzanne Fletcher; Ann M Geiger; Lisa J Herrinton; Mark C Hornbrook; Christine C Johnson; Judy Mouchawar; Sharon J Rolnick; Victor J Stevens; Stephen H Taplin; Dennis Tolsma; Thomas M Vogt
Journal:  J Natl Cancer Inst Monogr       Date:  2005

3.  Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians.

Authors:  L Wideroff; S T Vadaparampil; M H Greene; S Taplin; L Olson; A N Freedman
Journal:  J Med Genet       Date:  2005-03-22       Impact factor: 6.318

4.  Uptake of hereditary breast/ovarian cancer genetic testing in a French national sample of BRCA1 families. The French Cancer Genetic Network.

Authors:  C Julian-Reynier; H Sobol; C Sévilla; C Noguès; P Bourret
Journal:  Psychooncology       Date:  2000 Nov-Dec       Impact factor: 3.894

5.  Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.

Authors:  C Lerman; B Biesecker; J L Benkendorf; J Kerner; A Gomez-Caminero; C Hughes; M M Reed
Journal:  J Natl Cancer Inst       Date:  1997-01-15       Impact factor: 13.506

6.  Interviews with primary care physicians regarding taking and interpreting the cancer family history.

Authors:  Marie E Wood; Alan Stockdale; Brian S Flynn
Journal:  Fam Pract       Date:  2008-09-01       Impact factor: 2.267

7.  Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancer.

Authors:  Kathryn J Schlich-Bakker; Herman F J ten Kroode; Carla C Wárlám-Rodenhuis; Jan van den Bout; Margreet G E M Ausems
Journal:  Genet Med       Date:  2007-11       Impact factor: 8.822

8.  Diffusion of breast cancer risk assessment in primary care.

Authors:  Carmen E Guerra; Melani Sherman; Katrina Armstrong
Journal:  J Am Board Fam Med       Date:  2009 May-Jun       Impact factor: 2.657

9.  American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

Authors: 
Journal:  J Clin Oncol       Date:  2003-04-11       Impact factor: 44.544

10.  Validation of My Family Health Portrait for six common heritable conditions.

Authors:  Flavia M Facio; W Gregory Feero; Amy Linn; Neal Oden; Kandamurugu Manickam; Leslie G Biesecker
Journal:  Genet Med       Date:  2010-06       Impact factor: 8.822

View more
  15 in total

1.  Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter.

Authors:  Alyssa Kne; Heather Zierhut; Shari Baldinger; Karen K Swenson; Pamela Mink; Patricia McCarthy Veach; Michaela L Tsai
Journal:  J Genet Couns       Date:  2016-11-08       Impact factor: 2.537

Review 2.  Review and Comparison of Electronic Patient-Facing Family Health History Tools.

Authors:  Brandon M Welch; Kevin Wiley; Lance Pflieger; Rosaline Achiangia; Karen Baker; Chanita Hughes-Halbert; Heath Morrison; Joshua Schiffman; Megan Doerr
Journal:  J Genet Couns       Date:  2018-03-06       Impact factor: 2.537

3.  Initial clinical validation of Health Heritage, a patient-facing tool for personal and family history collection and cancer risk assessment.

Authors:  Leigh A Baumgart; Kristen J Vogel Postula; William A Knaus
Journal:  Fam Cancer       Date:  2016-04       Impact factor: 2.375

4.  Using a family history questionnaire to identify adult patients with increased genetic risk for sarcoma.

Authors:  A Schiavi; J Lavigne; R Turcotte; L Kasprzak; N Dumas; G Chong; C Freeman; M Alameldin; P Galiatsatos; L Palma; W D Foulkes
Journal:  Curr Oncol       Date:  2015-10       Impact factor: 3.677

5.  Models of service delivery for cancer genetic risk assessment and counseling.

Authors:  Angela M Trepanier; Dawn C Allain
Journal:  J Genet Couns       Date:  2013-10-26       Impact factor: 2.537

6.  Outcomes of a systems-level intervention offering breast cancer risk assessments to low-income underserved women.

Authors:  Darren Mays; McKane E Sharff; Tiffani A DeMarco; Bernice Williams; Beth Beck; Vanessa B Sheppard; Beth N Peshkin; Jennifer Eng-Wong; Kenneth P Tercyak
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

7.  All in the Family: Barriers and Motivators to the Use of Cancer Family History Questionnaires and the Impact on Attendance Rates.

Authors:  Susan Randall Armel; Jeanna McCuaig; Nicole Gojska; Rochelle Demsky; Manjula Maganti; Joan Murphy; Barry Rosen
Journal:  J Genet Couns       Date:  2015-01-07       Impact factor: 2.537

8.  Medical mistrust influences black women's level of engagement in BRCA 1/2 genetic counseling and testing.

Authors:  Vanessa B Sheppard; Darren Mays; Thomas LaVeist; Kenneth P Tercyak
Journal:  J Natl Med Assoc       Date:  2013       Impact factor: 1.798

9.  Associations of sociodemographic and clinical factors with gastrointestinal cancer risk assessment appointment completion.

Authors:  Jessica E Ebrahimzadeh; Jessica M Long; Louise Wang; John T Nathanson; Shazia Mehmood Siddique; Anil K Rustgi; David S Goldberg; Bryson W Katona
Journal:  J Genet Couns       Date:  2020-03-30       Impact factor: 2.537

10.  Analysis of patient reports on the referral process to two NSW cancer genetic services.

Authors:  Grace I Butel-Simoes; Allan D Spigelman
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.